Key safety considerations include: Infection risk : Any injection carries risk of infection if proper aseptic technique is not followed Allergic reactions : Multiple ingredients increase the potential for hypersensitivity Undiagnosed conditions : Self-administration or private clinic use may delay diagnosis of underlying medical conditions Pregnancy and breastfeeding : Safety data for lipotropic formulations in pregnancy is lacking Call 999 immediately if you experience signs of anaphylaxis (difficulty breathing, facial/tongue swelling, collapse) after an injection
Understanding Semaglutide Semaglutide is an FDA-approved GLP-1 receptor agonist, specifically designed for adults living with obesity or those who are overweight with at least one weight-related condition
It is whether the processes around eating change: food noise, control, shame, body image, emotion regulation
Private prescriptions are also available
Instruct patients to inform healthcare providers prior to any planned surgeries or procedures if they are taking Saxenda Adverse Reactions The most common adverse reactions, reported in 5% are nausea, diarrhea, constipation, vomiting, injection site reactions, headache, hypoglycemia, dyspepsia, fatigue, dizziness, abdominal pain, increased lipase, upper abdominal pain, pyrexia, and gastroenteritis Drug Interactions Saxenda causes a delay of gastric emptying and has the potential to impact the absorption of concomitantly administered oral medications